Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
03/18/2009 | CN100469778C Novel fused imidazole derivative |
03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
03/18/2009 | CN100469390C Use of bromelain in preparing medicament for increasing individual IL-8 content |
03/18/2009 | CN100469379C Medical liquor for curing rheumatic numbness |
03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
03/18/2009 | CN100469357C Tablet for treating difficult menstruation and its preparation |
03/18/2009 | CN100469355C Nutritional supplements and methods of using same |
03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
03/17/2009 | US7504482 Recombinant soluble Fc receptors |
03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
03/17/2009 | US7504237 Polynucleotides encoding interferon gamma polypeptides |
03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
03/17/2009 | CA2359116C Substituted porphyrins |
03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
03/12/2009 | WO2009031878A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency |
03/12/2009 | WO2009031877A1 Pharmaceutical composition combining acemetacin, methocarbamol and diacerein, which can be used in the treatment of rheumatoid arthritis and related diseases |
03/12/2009 | WO2009031826A1 Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same |
03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
03/12/2009 | WO2009031627A1 Para-terphenyl compound or pharmacologically acceptable salt thereof, method for production of the same, and use of the same |
03/12/2009 | WO2009031606A1 Therapeutic and prophylactic agents for arthritis |
03/12/2009 | WO2009031318A1 Preparation for external application comprising analgesic/anti-inflammatory agent |
03/12/2009 | WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
03/12/2009 | WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity |
03/12/2009 | WO2009007680A3 Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders |
03/12/2009 | WO2009007679A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
03/12/2009 | WO2009007675A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
03/12/2009 | WO2008149244A3 Compositions and methods comprising analogues of radicicol a |
03/12/2009 | WO2008109498A3 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
03/12/2009 | WO2006122806A3 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors |
03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |
03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
03/12/2009 | US20090069426 Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid |
03/12/2009 | US20090069383 Thrombin Receptor Antagonists |
03/12/2009 | US20090069373 Quinoline Acids |
03/12/2009 | US20090069347 2-phenoxy pyrimidinone analogues |
03/12/2009 | US20090069338 Method for predicting skin sensitizing activity of compounds |
03/12/2009 | US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
03/12/2009 | US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof |
03/12/2009 | US20090069310 Anti-inflammatory medicaments |
03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
03/12/2009 | US20090069303 Phthalazinone derivatives |
03/12/2009 | US20090069277 Compounds and compositions for treating infection |
03/12/2009 | US20090069259 Treatment of neuropathic pain with zinc finger proteins |
03/12/2009 | US20090069225 Somatostatin analogues |
03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
03/12/2009 | US20090068720 Useful polypeptides |
03/12/2009 | US20090068289 Formulation for menopausal women |
03/12/2009 | US20090068265 Ecklonia cava extracts for alleviating or preventing asthmatic reactions |
03/12/2009 | US20090068262 Rapid dissolution of combination products |
03/12/2009 | US20090068198 Antibody and Uses Thereof |
03/12/2009 | US20090068195 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
03/12/2009 | US20090068180 treating rheumatoid arthritis or graft-versus-host disease, comprising administering a Sphingosine-1-phosphate lyase inhibitors such as 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime and at least one additional immunosuppressant and/or antiinflammatory agent |
03/12/2009 | US20090068157 Derivation of unlimited quantities of neutrophils on monocyte/dendritic cells |
03/12/2009 | US20090068150 Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same |
03/12/2009 | US20090068143 Orally effective cannabinoid analogs |
03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
03/11/2009 | EP2033972A1 Screening method for candidate drugs |
03/11/2009 | EP2033955A1 Urea derivatives of 1H-pyrazol-4-carboxylic acid with neutrophil chemotaxis inhibiting activity |
03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
03/11/2009 | EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
03/11/2009 | EP2033659A2 Inhibitors of complement activation |
03/11/2009 | EP2033658A1 Anitbodies to cytokines in the prevention and treatment of inflammatory bowel disease |
03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
03/11/2009 | EP2033646A1 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
03/11/2009 | EP2032748A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
03/11/2009 | EP2032573A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
03/11/2009 | EP2032555A1 Pyrrole derivatives with crth2 receptor modulator activity |
03/11/2009 | EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines |
03/11/2009 | EP2032539A2 Benzazepinones as sodium channel blockers |
03/11/2009 | EP2032170A1 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
03/11/2009 | EP2032147A1 Cox-2 inhibitor |
03/11/2009 | EP2032128A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
03/11/2009 | EP1888027B1 Medicated product for local use based on natural materials |
03/11/2009 | EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb |
03/11/2009 | EP1517919B1 Marked peptides having affinity for a phospholipid and uses |
03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/11/2009 | EP1411899B1 Taste masking composition |
03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
03/11/2009 | EP1318801B1 Topical analgesic compositions containing aliphatic polyamines and methods of using same |